Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Double-blind, Placebo-controlled Multicenter Study Evaluating Stibium Metallicum Praeparatum D6 for Reducing Chemotherapy-induced Peripheral Neuropathy in Breast and Gynecological Cancer Patients Receiving Paclitaxel

NCT04715542 is registered in ClinicalTrials.gov with University of Bern as lead sponsor.

NCT NCT04715542
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04715542 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Double-blind, Placebo-controlled Multicenter Study Evaluating Stibium Metallicum Praeparatum D6 for Reducing Chemotherapy-induced Peripheral Neuropathy in Breast and Gynecological Cancer Patients Receiving Paclitaxel
Lead sponsor
University of Bern
Phase
Phase 3
Overall status
Not yet recruiting
Start date
January 31, 2027
Completion date
December 31, 2029
Enrollment
86 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

chemotherapy induced peripheral neuropathy (cipn)